Haven't bothered to look at the short yappers today. Hard to imagine what kind of doofus trader goes short such a tiny float tiny market cap stock with an FDA okayed Phase III, an NDA in the works, a patent, and an existing first negotiation deal with a multi-billion $ pharma company.
Market Data 
Markets 
AI
